FELDENE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Israel, Italy, Japan, Mexico, Poland, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug FELDENE contains one active pharmaceutical ingredient (API):

1 Piroxicam
UNII 13T4O6VMAM - PIROXICAM

Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.

Read about Piroxicam

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FELDENE Capsule, FELDENE D Tablet Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AC01 Piroxicam M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC01
M02AA07 Piroxicam M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1896T, 1897W, 1898X, 5202T, 5203W, 5204X
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522717120067017, 522717120067117, 522717120067217, 522717120067317, 522717120067417, 522717120067517, 522717120067617, 522717120067717, 522717120067817, 522718100081803
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 30185-04-12, 3037-MEE-0917
Country: EE Ravimiamet Identifier(s): 1018516
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 55382, 55806, 58085, 60070
Country: FR Base de données publique des médicaments Identifier(s): 65182102, 65898475, 67214342, 67633600
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 138762, 142326, 161757, 181683, 181687, 182568, 24557, 24559, 381333
Country: HK Department of Health Drug Office Identifier(s): 46650
Country: IE Health Products Regulatory Authority Identifier(s): 24066
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2669
Country: IT Agenzia del Farmaco Identifier(s): 024249029, 024249068
Country: JP 医薬品医療機器総合機構 Identifier(s): 2649730M1077
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 047M86, 068M87, 188M80, 439M86
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100023759, 100264530, 100290443, 100340402, 100434830, 100451782
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 9243011, 9243012, 9243013, 9243015, 9243016
Country: US FDA, National Drug Code Identifier(s): 0069-3220, 0069-3230
Country: ZA Health Products Regulatory Authority Identifier(s): M/3.1/0007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.